Diversify Advisory Services LLC Acquires New Stake in Agilent Technologies, Inc. $A

Diversify Advisory Services LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) during the second quarter, Holdings Channel.com reports. The institutional investor bought 3,232 shares of the medical research company’s stock, valued at approximately $446,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp raised its stake in Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after purchasing an additional 241,029 shares in the last quarter. Geode Capital Management LLC lifted its position in Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after purchasing an additional 25,139 shares during the last quarter. Deutsche Bank AG grew its stake in Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after buying an additional 1,024,516 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after buying an additional 692,202 shares in the last quarter.

Agilent Technologies Stock Up 0.7%

Shares of NYSE:A opened at $156.50 on Friday. The stock’s 50-day moving average is $136.98 and its 200 day moving average is $126.00. The company has a market cap of $44.20 billion, a PE ratio of 31.43, a P/E/G ratio of 2.75 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the company earned $1.31 EPS. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Royal Bank Of Canada started coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price on the stock. Jefferies Financial Group started coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target for the company. Barclays upped their price objective on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. TD Cowen raised their price objective on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.